Symptom‐Based Clinical Deterioration as a Patient‐Centred Endpoint in Canine Urothelial Carcinoma
Veterinary and Comparative Oncology · 19.11.2026
DOI: 10.1111/vco.70132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 19.11.2026. Verfasst von JiHyun Lim und 6 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University.
Abstract (Originalsprache)
This multicentre retrospective cohort study operationalized structured clinical deterioration endpoints in canine urothelial carcinoma (UC) and compared them with conventional outcomes. A total of 182 dogs with imaging‐supported, cytologically and/or histopathologically confirmed UC from three referral institutions were included. Clinical signs were retrospectively mapped using prespecified grading rules anchored to VCOG‐CTCAE v2 and symptom‐based endpoints were defined from treatment initiation as time to lower urinary tract symptom progression (TTSP) and time to systemic deterioration (TTD), each assessed as initial (first grade ≥ 2 deterioration) and confirmed (grade ≥ 2 deterioration sustained at the next consecutive assessment) events. Imaging‐based progression‐free survival (PFS) was reconstructed from serial ultrasonography using VCOG cRECIST progression criteria (≥ 20% increase in longest tumour diameter or a new lesion). Confirmed TTSP and TTD were strongly associated with OS (rank correlations, 0.81 and 0.82, respectively) and remained prognostically informative in multivariable models and at most prespecified landmark times; the corresponding correlation for imaging‐based PFS was 0.74. TTSP/TTD were not temporally interchangeable with imaging‐based PFS or with acute kidney injury (AKI) and complete obstruction, showing broad individual‐level discordance and limited overlap even within ±7‐ and ±14‐day windows. In descriptive treatment‐group comparisons, patterns differed across OS, PFS and deterioration endpoints and in the rescue‐intervention subcohort, most dogs developed recurrent deterioration after decompression for malignant obstruction. These findings suggest that TTSP/TTD are feasible structured endpoints that capture clinically relevant and prognostically informative worsening not fully represented by imaging progression or catastrophic events alone.
Förderung
- Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University
Zitieren
APA
Lim, J., Kim, J., Hong, Y., Park, J., Kim, S., Ryu, M., & Seo, K. (2026). Symptom‐Based Clinical Deterioration as a Patient‐Centred Endpoint in Canine Urothelial Carcinoma. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.70132
Vancouver
Lim J, Kim J, Hong Y, Park J, Kim S, Ryu M, et al. Symptom‐Based Clinical Deterioration as a Patient‐Centred Endpoint in Canine Urothelial Carcinoma. Veterinary and Comparative Oncology. 2026. doi:10.1111/vco.70132
BibTeX
@article{Lim2026,
author = {Lim, JiHyun and Kim, Jin‐Kyung and Hong, Yeon‐Jung and Park, Jung‐Hoon and Kim, Se‐Hoon and Ryu, Min‐Ok and Seo, Kyoung‐Won},
title = {Symptom‐Based Clinical Deterioration as a Patient‐Centred Endpoint in Canine Urothelial Carcinoma},
journal = {Veterinary and Comparative Oncology},
year = {2026},
doi = {10.1111/vco.70132}
}
EUVIMED